Netherlands · Series A startup

Who invested in Kynexis

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$61Mraised across 1 round since 2023, from 1 source

Latest round
Series A, $61MNov 2023
Investors
1
See who backed them

The rounds

  1. Nov 2023
    Series A$61M

    Source recorded

Founders and team

From Kynexis's own website: 1 founder, 8 on the team.

Christer KöhlerFounding Director
  • Kees BeenChief Executive Officer
  • Neil SwamiChief Business Officer
  • Amy ArchambaultHead of Finance
  • Cheryl NewHead of Quality
  • Elisa YoritomiSenior Director, Head of Clinical Operations
  • Adam RosenbergIndependent Board Member
  • Lauren CortellessaDirector of Operations
  • Peter HøngaardExecutive Chairman

AdvisersJohn MacDonald

Everyone who backed them

Forbion Capital PartnersPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Kynexis

Who invested in Kynexis?

Kynexis's investors include Forbion Capital Partners.

How much has Kynexis raised?

Kynexis has raised $61M across 1 round since 2023.

When did Kynexis last raise?

Kynexis's most recent round was a Series A of $61M in Nov 2023.

What was Kynexis's biggest round?

Its most recent round, $61M in Nov 2023, is also its largest on record.

Who backed Kynexis first?

Kynexis's first round on record, in Nov 2023, was backed by Forbion Capital Partners.

What stage is Kynexis at?

Kynexis's latest named round is a Series A, in Nov 2023.

Where is Kynexis based?

Kynexis is based in the Netherlands.

Companies like Kynexis

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.